Chief physician at First Hospital of Shanxi Medical University, China
Dr. Yang Li is a distinguished Chief Neurologist at the First Hospital of Shanxi Medical University, with over three decades of experience in cognitive disorder research and clinical practice. He holds a Doctor of Medicine (M.D.) degree and serves as a doctoral advisor. As the head of the Core Advanced Cognitive Center, he has played a pivotal role in advancing cognitive health initiatives in China. His contributions include the establishment of Shanxi Province’s first memory clinic in 2009, which received national recognition in subsequent years. Dr. Li has spearheaded multiple projects focused on Alzheimer’s disease (AD) and Parkinson’s disease (PD), significantly enhancing early detection and patient care strategies. Recognized for his exceptional contributions, he has been awarded the Second Prize of the Shanxi Provincial Science and Technology Progress Award and was selected as a leading talent under the “San Jin Talents” Support Program.
Profile
Scopus
Education
Dr. Yang Li obtained his Doctor of Medicine (M.D.) degree, equipping him with the expertise necessary for his extensive work in neurology and cognitive disorders. As a dedicated academic, he has mentored numerous doctoral candidates, guiding them in clinical research. His academic journey reflects a strong commitment to advancing neurological science, particularly in memory and cognitive function research. His efforts have contributed significantly to the development of national health policies and innovative diagnostic techniques for neurodegenerative disorders.
Experience
With more than 30 years in the field, Dr. Li has played a transformative role in neurology, specializing in cognitive disorders. His leadership at the First Hospital of Shanxi Medical University has resulted in numerous breakthroughs in early detection and treatment methodologies for conditions such as Alzheimer’s and Parkinson’s disease. Dr. Li has also been instrumental in establishing national training programs, including the Cognitive Specialty Capacity Building Project initiated by the National Health Commission. His expertise extends beyond clinical practice to impactful policy formulation and implementation. His work in digital screening tools and community-based healthcare projects underscores his innovative approach to neurological health.
Research Interests
Dr. Li’s research is primarily centered on cognitive disorders, particularly Alzheimer’s disease and other neurodegenerative conditions. He has pioneered advancements in early screening tools and interventions, integrating digital diagnostics such as neuroimaging assessments, PET-CT scans, and gait analysis. His recent initiatives focus on community-based screening, aiming to develop scalable and efficient methods for detecting mild cognitive impairment (MCI) and dementia in aging populations. His work contributes significantly to global research in cognitive health, emphasizing preventive strategies and innovative therapeutic approaches.
Awards
Dr. Li’s contributions to cognitive neurology have earned him numerous accolades. He was honored with the Second Prize of the Shanxi Provincial Science and Technology Progress Award in recognition of his pioneering research in neurodegenerative disorders. In 2018, he was selected as a leading talent under the “San Jin Talents” Support Program. His memory clinic, established in 2009, was recognized as a “National Outstanding Memory Clinic” in both 2013 and 2014. His dedication to advancing early screening and intervention methods for cognitive impairments has positioned him as a key figure in neurological research and healthcare innovation.
Publications
Dr. Li has contributed extensively to the scientific community with high-impact publications in leading journals. Some of his notable works include:
Qin Y, Han H, Li Y, et al. (2023). “Estimating Bidirectional Transitions and Identifying Predictors of Mild Cognitive Impairment.” Neurology, 100(3), e297-e307. [Cited by 120 articles].
Jia J, Zhao T, Liu Z, et al. (2023). “Association between Healthy Lifestyle and Memory Decline in Older Adults: 10-Year Prospective Cohort Study.” BMJ, 380, e072691. [Cited by 95 articles].
Wu H, Ren Z, Gan J, et al. (2022). “Blood Pressure Control and Risk of Post-Stroke Dementia.” Front Neurol, 13, 1069667. [Cited by 87 articles].
Zhang X, Lv L, Min G, Wang Q, Zhao Y, Li Y. (2021). “Complex Figure Test and Its Clinical Application in Neuropsychiatric Disorders.” Front Neurol, 12, 680474. [Cited by 78 articles].
Xu SY, Song MM, Liu DY, et al. (2024). “Contrast-Induced Encephalopathy with Elevated Cerebrospinal Fluid Protein.” Br J Neurosurg, 38(4), 963-967. [Cited by 56 articles].
Wang F, Fei M, Hu WZ, et al. (2022). “Prevalence of Constipation in Elderly and Its Association with Dementia.” Front Neurosci, 15, 821654. [Cited by 102 articles].
Xing Y, Zhu Z, Du Y, et al. (2020). “COG-REAGENT: Cognitive Training in Amnestic Mild Cognitive Impairment.” J Alzheimers Dis, 75(3), 779-787. [Cited by 112 articles].
Conclusion
Dr. Yang Li has made remarkable contributions to cognitive neurology through his pioneering research, clinical expertise, and commitment to early detection of neurodegenerative disorders. His leadership in community-based screening projects and digital health interventions has significantly advanced the field of cognitive disorders. With numerous prestigious awards, high-impact publications, and dedicated mentorship, Dr. Li continues to shape the landscape of Alzheimer’s and dementia research. His work not only enhances diagnostic methodologies but also fosters preventive healthcare strategies, making a lasting impact on the global fight against cognitive decline.